drugset / Trial / NCT04508907
A Study to Evaluate Preemptive Therapy in Hepatitis C (HCV) Organ Transplant Recipients
NaSingle-groupOpen-labelTreatment
Summary
This study is being done to determine the effectiveness of using a combination of two different drugs in preventing the transmission of HCV from a HCV positive donor to a HCV negative solid organ recipient.
Timeline
- Start
- 2020-09-10
- Primary completion
- 2025-11-01
- Completion
- 2026-11-01
Drugs
| Evaluation | Drug | Modality | Dose | Route |
|---|---|---|---|---|
| Subject | Ezetimibe | Unknown | — | — |
| Subject | glecaprevir | Other / unclassified | — | — |